Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by B52paul


C.AGN

Where is the Fda results ??? ALGERNON !!

70 DAYS !

July 5, 2021

C.AGN

Management doesn’t respond

JULY 2ND 2021 What are the Bad signs for investors..... ( Algernon...

July 2, 2021

C.AGN

Countdown !

www.datecountdown.com/?&d=07%2f05%2f2021+12%3a00+AM&t=FDA+#timer1

June 21, 2021

C.AGN

70 days almost !

https://howlongagogo.com/date/2021/april/26

June 21, 2021

C.AGN

70 days. Almost !

VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) The FDA...

June 21, 2021

C.AGN

CEO Christopher Moreau TALKING PHASE 3

CEO Christopher Moreau TALKING IN THESE VIDEOS , IF IFENPRODIL GO PHASE 3. ...

March 31, 2021

C.AGN

( CANADA ) investments of more than $1 billion

Over the last 12 months, the government has made investments of more than $1...

March 31, 2021

C.AGN

Merck’s Phase 3 Drug MK-7264 (Gefapixant)

IF FDA APPROVED Merck’s Phase 3 Drug MK-7264 (Gefapixant) ...

March 11, 2021

C.AGN

RE:Algernon Pharmaceuticals Provides Update March 11, 2021

March 11, 2021 07:41 ET  | Source: Algernon Pharmaceuticals ...

March 11, 2021

C.AGN

Algernon Pharmaceuticals Provides Update March 11, 2021

https://www.globenewswire.com/news-release/2021/03/11/2191278/0/en/Algernon...

March 11, 2021

C.AGN

possible negotiation with big pharma ?

      (Closing your biopharma deal)   www...

March 10, 2021

C.AGN

Emergency Use Authorization (FDA )

https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory...

March 8, 2021

C.AGN

NP-120 (Ifenprodil) Phase 3

Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3...

March 3, 2021

C.AGN

RE:Ifenprodil phase 3

ALGERNON PHARMACEUTICALS’ NP-120 (IFENPRODIL) OUTPERFORMS MERCK’S PHASE 3...

February 24, 2021

C.AGN

Ifenprodil phase 3

February 24, 2021

C.AGN

$1M Donation for Research to Prevent Lung Scarring

https://pulmonaryfibrosisnews.com/2021/02/19/usf-receives-1m-dollar-private...

February 24, 2021

C.AGN

Phase 3 Study of Ifenprodil for COVID-19

UF startup Algernon Pharmaceuticals Inc., formerly known as Breathtec...

February 23, 2021

C.AGN

SEDI Insider Filings 2021-02-19

Recent filings  Filed 2021-02-19 14:23 ...

February 19, 2021

C.AGN

The database will be locked for analysis on March 5th

data audit from all sites and for all patients is now complete. the Company...

February 17, 2021

C.AGN

RE:RE:RE:No patent = No commercialization

https://patentscope.wipo.int/search/docs2/pct/WO2020163966/pdf/rJy8W7UIE...

February 9, 2021

1 2 Next

Featured Company